Authors: SCOTT C MOVSAS B SAUSE W BYHARDT R KOMAKI R COX J JOHNSON D LAWTON C DAR AR WASSERMAN T ROACH M LEE JS ANDRAS EJ

Citation: C. Scott et al., INTENSIFIED TREATMENT INCREASES SURVIVAL IN PATIENTS WITH NONSMALL CELL OF LIFE AND OPTIMISM LUNG-CANCER AT WHAT PRICE - A QUALITY-ADJUSTEDSURVIVAL ANALYSIS OF RADIATION-THERAPY ONCOLOGY GROUP CHEMORADIATION STUDIES, Quality of life research, 6(7-8), 1997, pp. 345-345

Authors: WERNERWASIK M SCOTT C GRAHAM ML SMITH C BYHARDT RW ROACH M ANDRAS EJ

Citation: M. Wernerwasik et al., INTERFRACTION INTERVAL DOES NOT AFFECT SURVIVAL OF PATIENTS WITH NONSMALL CELL LUNG-CANCER TREATED WITH HYPERFRACTIONATED RADIOTHERAPY WITHWITHOUT CHEMOTHERAPY - A MULTIVARIATE-ANALYSIS OF 682 RTOG PATIENTS/, International journal of radiation oncology, biology, physics, 39(2), 1997, pp. 314-314

Authors: KOMAKI R SCOTT C LEE JS URTASUN RC BYHARDT RW EMAMI B ANDRAS EJ ASBELL SO ROTMAN M COX JD

Citation: R. Komaki et al., IMPACT OF ADDING CONCURRENT CHEMOTHERAPY TO HYPERFRACTIONATED RADIOTHERAPY FOR LOCALLY ADVANCED NONSMALL CELL LUNG-CANCER (NSCLC) - COMPARISON OF RTOG-83-11 AND RTOG-91-06, American journal of clinical oncology, 20(5), 1997, pp. 435-440

Authors: ROSENTHAL SA LINSTADT DE LEIBENHAUT MH ANDRAS EJ BROOKS CP STICKNEY DR CHANG GC WOLKOV HB GILBERT RM

Citation: Sa. Rosenthal et al., FLUTAMIDE-ASSOCIATED LIVER TOXICITY DURING TREATMENT WITH TOTAL ANDROGEN SUPPRESSION AND RADIATION-THERAPY FOR PROSTATE-CANCER, Radiology, 199(2), 1996, pp. 451-455

Authors: ROSENTHAL SA LEIBENHAUT MH GILBERT RM ANDRAS EJ BROOKS CP WOLKOV HB

Citation: Sa. Rosenthal et al., FLUTAMIDE TOXICITY IN PATIENTS TREATED WITH TOTAL ANDROGEN SUPPRESSION FOR PROSTATE-CANCER - SIGNIFICANT INCIDENCE OF HEPATIC AND HEMATOLOGIC TOXICITY, Radiology, 197, 1995, pp. 224-224